ArticlePloS one2010

JAK2 V617F constitutive activation requires JH2 residue F595: a pseudokinase domain target for specific inhibitors.

Alexandra Dusa et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.